Merck Agrees to Pay $4.85B in Vioxx Settlement

Pharmaceutical giant Merck (MRK) will pay $4.85 billion to settle most of the nearly 27,000 pending Vioxx lawsuits nationwide in one of the largest civil agreements ever, the company announced Friday.

Merck Agrees to $4.85 Billion Vioxx Settlement

The maker of the painkiller Vioxx has agreed to pay more than $4.8 billion to settle thousands of lawsuits in one of the largest civil cases ever.

$4.85B Vioxx Settlement Announced

Plaintiffs' lawyers this morning announced that Merck & Co. has agreed to pay $4.85 billion to settle the majority of claims over injuries linked to its Vioxx painkiller.

Vioxx Settlement Worth $4.85 Billion

Company officials estimated the deal, if accepted, would end 45,000 to 50,000 personal injury lawsuits involving U.S. Vioxx users who suffered a heart attack or ischemic stroke, the type in which blood flow to the brain is blocked.

Merck to Pay $4.85B Vioxx Settlement

Merck & Co. said Friday it will pay $4.85 billion to end thousands of lawsuits over its painkiller Vioxx in what is believed to be the largest drug settlement ever.

49 File Another Fen-Phen Lawsuit

A Lexington lawyer has been sued by 49 former diet drug users who say they were cheated out of a combined $903,000 in a settlement of a lawsuit in Mississippi.

Jury Can Hear 7 Tapes of Ex-General Re Executives

Jurors at the fraud trial of four former General Reinsurance Corp. executives can hear a taped conversation in which a witness said American International Group Inc. will "find ways to cook the books," a U.S. judge ruled.

Binding Arbitration Bad for Consumers

You may have never heard of Binding Mandatory Arbitration, but that would not prevent this unfair practice, visited on unsuspecting consumers, from destroying your life.

By Mandatory Arbitration We Lost Our Home and Our Right to a Trial by a Jury

The first night in our new home, my husband tried out new Jacuzzi tub on the third floor. When he pulled the plug, 100 gallons of water crashed through our dining room ceiling into the dining room.

Avandia Vote at FDA Kept Secret, Leads to Questions from US Senator

Avandia may have been the subject of a secret vote by a Food & Drug Administration (FDA) panel in which it apparently decided by a one-vote margin to keep the controversial drug on the market.